Machine Learning and Radiomics in Gliomas.

Area of Science:

• Neuro-oncology
• Medical Imaging Analysis
• Artificial Intelligence in Medicine

Background:

• Gliomas are complex brain tumors requiring advanced diagnostic and prognostic tools.
• Traditional methods for glioma analysis have limitations in precision and detail.
• Radiomics and machine learning (ML) offer novel approaches to overcome these limitations.

Purpose of the Study:

• To examine the application of supervised and unsupervised ML techniques in interpreting radiomic data for glioma research.
• To highlight the potential of ML-based radiomics in predicting tumor grade, identifying mutations, estimating survival, and evaluating treatment response.
• To underscore the importance of integrating these technologies into clinical practice for personalized medicine.

Main Methods:

• Extraction of quantitative features from medical images (radiomics).
• Application of supervised and unsupervised machine learning algorithms to analyze radiomic data.
• Assessment of ML-based radiomic analysis for discerning intricate patterns in tumor imaging.

Main Results:

• Enhanced precision in tumor characterization beyond traditional methods.
• Potential for accurate prediction of tumor grade, genetic mutations, and patient survival rates.
• Improved evaluation of treatment responses through analysis of subtle imaging patterns.

Conclusions:

• The integration of ML and radiomics represents a significant advancement in glioma research.
• ML-based radiomic analysis offers enhanced tools for patient-specific treatment strategies and personalized medicine.
• Addressing challenges like data diversity and clinical integration is crucial for effective utilization.